BPA for tryngolza
Ended Awarded Last action
- Contract number
- 36E79725A0020
- Awardee
-
Ionis Pharmaceuticals, Inc. UEI P8PVTLSDNNS6
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $4,257,639.80
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA), awarded to Ionis Pharmaceuticals, Inc. on June 16, 2025, establishes a single-award indefinite delivery vehicle with a ceiling value of $4.26 million and an ultimate completion date of September 2, 2025. The agreement is funded through the National Acquisition Center, a civilian federal agency, and does not employ any set-asides. The BPA procures TryngolZA, a specialized pharmaceutical product, with this agreement replacing a prior BPA (36E79725A0020). Ionis Pharmaceuticals, a for-profit pharmaceutical company headquartered in Carlsbad, California, and registered in the System for Award Management since June 2001, serves as the prime contractor and possesses specialized capabilities in hematology-related pharmaceutical development and drug delivery.
Ionis Pharmaceuticals demonstrates established capacity to fulfill federal pharmaceutical procurement requirements through multiple concurrent contracts with various agencies, including significant Federal Supply Schedule holdings with the Department of Veterans Affairs and interim agreements supporting pharmaceutical distribution. The company's federal contracting portfolio reflects consistent engagement in providing specialized drug products to government entities, with contract values ranging substantially based on procurement scope. This BPA represents a critical procurement vehicle for ensuring federal agency access to TryngolZA, positioning Ionis Pharmaceuticals as a sole-source provider for this specialized pharmaceutical offering within the federal acquisition system during the specified performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0020?
36E79725A0020 was awarded to Ionis Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on June 16, 2025.
How much is contract 36E79725A0020 worth?
36E79725A0020's own ceiling is $4,257,640.
Who can order from contract 36E79725A0020?
36E79725A0020 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0020 under another contract?
Yes. 36E79725A0020 is a blanket purchase agreement under 36F79725D019E, a federal supply schedule.
Was contract 36E79725A0020 competed?
The extent of competition for 36E79725A0020 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV